Inbox Robot: Biogen Idec News http://www.inboxrobot.com/news/biogenConstantly updated news and information about a variety of topics. Not Teva's Forte http://www.inboxrobot.com/news.php?fid=177640148 8 Jul 2008 20:12 GMT ... The results shouldn't change how well Copaxone competes against other multiple sclerosis drugs like Biogen Idec 's Avonex or Rebif from EMD Serono and Pfizer . Granted, an extra ... Amorfix Provides Corporate Update on ALS Therapeutic Program http://www.inboxrobot.com/news.php?fid=177640056 8 Jul 2008 20:12 GMT ... Amorfix recently hosted a meeting of its Scientific Advisory Board and research collaboration partner Biogen Idec (NASDAQ: BIIB) to review progress and data from this program. All parties were ... New MedPredict Report Highlights Trend Toward Early Diagnosis and Treatment of Rheumatoid Arthritis, Impact on Pharmaceu http://www.inboxrobot.com/news.php?fid=177636683 8 Jul 2008 19:50 GMT ... and more. Companies mentioned in this report include: Abbott, Amgen, Amgen/ , Amgen/Wyeth, AstraZeneca/MedImmune, Biogen, Bristol-Myers Squibb, Celgene, Centocor, GlaxoSmithKline/Genmab, Human Genome Sciences, Incyte, Merck Serono/ZymoGenetics, Novartis, Oxypharma, Pfizer, ... New MedPredict Report Highlights Trend Toward Early Diagnosis and Treatment of Rheumatoid Arthritis, Impact on Pharmaceutical Development http://www.inboxrobot.com/news.php?fid=177633375 8 Jul 2008 19:25 GMT ... and more. Companies mentioned in this report include: Abbott, Amgen, Amgen/Takeda Bio, Amgen/Wyeth, AstraZeneca/MedImmune, Biogen, Bristol-Myers Squibb, Celgene, Centocor, GlaxoSmithKline/Genmab, Human Genome Sciences, Incyte, Merck Serono/ZymoGenetics, Novartis, Oxypharma, Pfizer, ... Nasdaq 100 Winners: Ryanair, UAL, Biogen http://www.inboxrobot.com/news.php?fid=177625628 8 Jul 2008 18:25 GMT ... BellwetherReport.com Analyst Report on IDCC, RBY, GENZ and BIIB http://www.inboxrobot.com/news.php?fid=177604997 8 Jul 2008 16:11 GMT ... InterDigital Inc. (NASDAQ: IDCC), Rubicon Minerals Corporation (AMEX: RBY), Genzyme Corp. (NASDAQ: GENZ) and Biogen Idec Inc. (NASDAQ: BIIB). To receive free access to these interviews and analyst reports ... Biogen Idec (BIIB) PriceWatch Alert With Support Around $57.30 http://www.inboxrobot.com/news.php?fid=177569689 8 Jul 2008 12:49 GMT ... Biogen Idec (BIIB) PriceWatch Alert With Support Around $57.30 Posted on Tuesday, July 08, 2008 ... Icahn also fighting clock in Yahoo board battle http://www.inboxrobot.com/news.php?fid=177561426 8 Jul 2008 12:19 GMT ... with. Last month, Icahn lost his bid for three out of four seats on Biogen Idec's board. In the Yahoo-Icahn proxy fight, the longer Icahn waits to file his ... Icahn also fighting clock in Yahoo board challenge http://www.inboxrobot.com/news.php?fid=177558964 8 Jul 2008 12:08 GMT ... with. Last month, Icahn lost his bid for three out of four seats on Biogen Idec's board. In the Yahoo-Icahn proxy fight, the longer Icahn waits to file his ... Genentech shares fall after arthritis patient's death in trial http://www.inboxrobot.com/news.php?fid=177553754 8 Jul 2008 11:53 GMT ... rheumatoid arthritis, generated $2.3 billion last year for South San Francisco-based Genentech and partner Biogen Idec of Cambridge, Mass. U.S. regulators told the companies in March to warn on ... Ichan's hedge funds fall 7 percent http://www.inboxrobot.com/news.php?fid=177523320 8 Jul 2008 06:29 GMT ... biggest investment. The 72-year-old billionaire also failed to persuade executives at Yahoo Inc. and Biogen Idec Inc. to take his advice for boosting their stock prices. ... Genentech shares drop on renewed Rituxan concerns http://www.inboxrobot.com/news.php?fid=177445077 7 Jul 2008 17:25 GMT ... leukoencephalopathy, a central nervous system disorder also known as PML, said a spokeswoman for Biogen Idec Inc (BIIB.O: ), which co-markets Rituxan in the United States with Genentech. The ... Biogen Idec to Report Second Quarter 2008 Financial Results on July 22, 2008 http://www.inboxrobot.com/news.php?fid=177442367 7 Jul 2008 16:55 GMT ... Following the release of the financials, the Company will host a live webcast where Biogen Idec management will discuss the financial results, at 8:30 am ET. To access the ... Out of the Gate: Teva drops on Copaxone results http://www.inboxrobot.com/news.php?fid=177437197 7 Jul 2008 16:30 GMT ... occurrence of new symptoms or the worsening of old symptoms. Rival MS drugs include Biogen Idec Inc.'s Avonex, and Biogen and Elan Corp. PLC's Tysabri. Mylan Inc. has the ... --> Neuro Sector Reviewed by NeuroInvestment http://www.inboxrobot.com/news.php?fid=177433563 7 Jul 2008 16:11 GMT ... June review of the Multiple Sclerosis area, featuring information on advanced programs from BioMS, Biogen-Idec, Active Biotech, and Novartis. The next issue of NeuroInvestment will be our annual review ...